<code id='DA838C2CD0'></code><style id='DA838C2CD0'></style>
    • <acronym id='DA838C2CD0'></acronym>
      <center id='DA838C2CD0'><center id='DA838C2CD0'><tfoot id='DA838C2CD0'></tfoot></center><abbr id='DA838C2CD0'><dir id='DA838C2CD0'><tfoot id='DA838C2CD0'></tfoot><noframes id='DA838C2CD0'>

    • <optgroup id='DA838C2CD0'><strike id='DA838C2CD0'><sup id='DA838C2CD0'></sup></strike><code id='DA838C2CD0'></code></optgroup>
        1. <b id='DA838C2CD0'><label id='DA838C2CD0'><select id='DA838C2CD0'><dt id='DA838C2CD0'><span id='DA838C2CD0'></span></dt></select></label></b><u id='DA838C2CD0'></u>
          <i id='DA838C2CD0'><strike id='DA838C2CD0'><tt id='DA838C2CD0'><pre id='DA838C2CD0'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:23
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Elizabeth Warren probes abortion access

          Sen.ElizabethWarren(D-Mass.)J.ScottApplewhite/APWASHINGTON—Sen.ElizabethWarren(D-Mass.)islaunchingaf